Indoco Remedies Share Price
Small Cap | Pharmaceuticals and health care | NSE: INDOCO | BSE: 532612
₹249.18 -6.39 (-2.50 %)
Last Updated: 04 Apr 2025 03:54 PM
Overview
Open (₹) 254.25
High (₹) 255.55
Low (₹) 240.64
Prev. Close (₹) 255.57
Volume 45,601
VWAP (₹) 195.08
ROCE (%) 10.59
Industry P/E 44.73
TTM P/E -216.68
P/B Ratio 2.07
Market Cap (₹) Cr.2,298.63
Dividend Yield (%)0.60
EPS (₹) 10.51
ROE8.72%
Sales Growth (%) 8.91
Profit Growth (%)-31.81
Day Range
255.55255.55
52 Week Range
190.00385.50
Historical Returns
Returns (6M)
-24.41 %
Returns (1Y)
-28.74 %
Returns (3Y)
-36.12 %
Returns (5Y)
2.06 %
Returns (6M)
-24.41 %
Returns (1Y)
-28.74 %
Returns (3Y)
-36.12 %
Returns (5Y)
2.06 %
SWOT Analysis
- Book value per share improving over the last 2 years
- Increasing Annual Revenue for Past 2 Years
- Strong short-term momentum: Price above short-term moving averages (EMA_10)
- Bullish MACD crossover (12,6,9) indicates potential upward price movement.
- Price above the pivot point indicates bullish sentiment.
Technicals
Technical Rating
RSI 22.65
MFI 4.42
ATR 12.76
Commodity Channel Index -185.95
ROC125 -46.21
ROC21 -19.86
Williams %R -92.83
Resistance & Support
Type | Resistance 1 | Resistance 2 | Resistance 3 | PP | Support 1 | Support 2 | Support 3 |
---|---|---|---|---|---|---|---|
Current | 204.32 | 212.16 | 219.32 | 197.16 | 189.32 | 182.16 | 174.32 |
Week Ago | 236.38 | 238.68 | 241.82 | 233.24 | 230.94 | 227.80 | 225.50 |
Month Ago | 256.56 | 265.78 | 271.56 | 250.78 | 241.56 | 235.78 | 226.56 |
EMA & SMA
249.18
Current Price
Bullish Moving Averages
13
Bearish Moving Averages
7
5 Day 219.76
9 Day 230.52
10 Day 230.92
12 Day 237.41
14 Day 240.19
20 Day 246.71
26 Day 251.25
50 Day 289.09
100 Day 304.95
200 Day 321.31
Deals & Announcements
Bulk and Block Deals
Client Name | Deal Type | Action | Date | Avg. Price | Quantity | Exchange |
---|---|---|---|---|---|---|
XTX MARKETS LLP | bulk | Sell | 12 Aug, 2021 | ₹508.51 | 4,81,713 | NSE |
XTX MARKETS LLP | bulk | Buy | 12 Aug, 2021 | ₹507.94 | 4,78,901 | NSE |
OHM JUNIPER LONGTERM FUND LTD | bulk | Sell | 02 Dec, 2020 | ₹265.31 | 5,00,000 | NSE |
DOVETAIL INDIA FUND CLASS 6 SHARES | bulk | Buy | 02 Dec, 2020 | ₹265.31 | 5,00,000 | NSE |
Insider Trading
Date | Name | Action | Avg. Price | Quantity | Deal Value |
---|---|---|---|---|---|
20 Mar, 2025 | Shanteri Investment Pvt Ltd | Acquisition | ₹229.59 | 12,150 | NSE |
19 Mar, 2025 | Shanteri Investment Pvt Ltd | Acquisition | ₹218.74 | 26,000 | NSE |
12 Mar, 2025 | Shanteri Investment Pvt Ltd | Acquisition | ₹222.23 | 2,600 | NSE |
11 Mar, 2025 | Shanteri Investment Pvt Ltd | Acquisition | ₹231.04 | 19,300 | NSE |
10 Mar, 2025 | Shanteri Investment Pvt Ltd | Acquisition | ₹235.00 | 8,153 | NSE |
06 Mar, 2025 | Shanteri Investment Pvt Ltd | Acquisition | ₹224.49 | 9,446 | NSE |
05 Mar, 2025 | Shanteri Investment Pvt Ltd | Acquisition | ₹224.79 | 9,401 | NSE |
17 Feb, 2025 | MADHURA SURESH KARE | Acquisition | ₹249.25 | 10,000 | NSE |
11 Feb, 2025 | MADHURA SURESH KARE | Acquisition | ₹259.85 | 9,500 | NSE |
29 Jan, 2025 | Sundeep V Bambolkar | Acquisition | ₹251.02 | 4,000 | NSE |
Corporate Actions
Announcement Date | Subject | Ex - Date | Record Date |
---|---|---|---|
16 May, 2024 | Rs.1.5000 per share(75%)Final Dividend | 19 Sept, 2024 | 01 Jan, 1970 |
23 May, 2023 | Rs.2.2500 per share(112.5%)Final Dividend | 18 Sept, 2023 | 01 Jan, 1970 |
18 May, 2022 | Rs.0.7500 per share(37.5%)Special Dividend | 14 Sept, 2022 | 01 Jan, 1970 |
Announcements
Date | Source | Detail |
---|---|---|
28 Mar, 2025 | NSE India | Indoco Remedies Limited has informed the Exchange about Closure of Trading Window |
28 Mar, 2025 | NSE India | Indoco Remedies Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 |
27 Mar, 2025 | NSE India | Indoco Remedies Limited has informed the Exchange about General Updates |
26 Mar, 2025 | NSE India | INDOCO REMEDIES LIMITED has informed the Exchange about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent |
25 Mar, 2025 | NSE India | Indoco Remedies Limited has informed the Exchange regarding Intimation under Regulation 8(2) of SEBI (Prohibition of Insider Trading) Regulations, 2015''''. |
25 Mar, 2025 | NSE India | Indoco Remedies Limited has informed the Exchange regarding Appointment of Ms Joshi Apte and Associates as Cost Auditor of the company w.e.f. March 25, 2025. |
25 Mar, 2025 | BSE India | The Board of Directors of the Company at their meeting held on 25-03-2025 has interalia considered and approved the following:\r\nReappointment of M/s. Joshi Apte & Associates, Cost Accountants, as the Cost Auditors of the Company for the financial year 2025-2026 |
12 Mar, 2025 | NSE India | Indoco Remedies Limited has informed the Exchange about Schedule of meet |
12 Mar, 2025 | BSE India | Pursuant to Regulation 30 (6) read with Schedule III OF THE SEBI (LODR) Regulation 2015, we wish to inform you that the management of the Company will be meeting investors and analysts on 21-03-2025 at the 10th Annual Valorem Analyst Conference. |
10 Mar, 2025 | NSE India | Indoco Remedies Limited has informed the Exchange regarding a press release dated March 10, 2025, titled ""Indoco''s Clinical Research Organisation- AnaCipher completes US FDA inspection"". |
Board Meetings
Purpose | Details | Meeting Date | Broadcast Date |
---|---|---|---|
Quarterly Results | -- | 14 Jan, 2025 | 21 Jan, 2025 |
Quarterly Results | -- | 15 Oct, 2024 | 24 Oct, 2024 |
Quarterly Results | -- | 11 Jul, 2024 | 23 Jul, 2024 |
Audited Results & Final Dividend | -- | 10 May, 2024 | 16 May, 2024 |
Quarterly Results | -- | 11 Jan, 2024 | 23 Jan, 2024 |
Quarterly Results | -- | 10 Oct, 2023 | 19 Oct, 2023 |
Quarterly Results | -- | 18 Jul, 2023 | 25 Jul, 2023 |
Audited Results & Final Dividend | -- | 15 May, 2023 | 23 May, 2023 |
Quarterly Results | -- | 12 Jan, 2023 | 24 Jan, 2023 |
Quarterly Results | -- | 24 Oct, 2022 | 10 Nov, 2022 |
Share Holding Pattern
Owner Name | Dec, 2024 | Dec, 2023 | Dec, 2022 | Dec, 2021 | Dec, 2020 |
---|---|---|---|---|---|
Promoter Group | 58.8% | 58.74% | 58.69% | 58.69% | 58.69% |
Foreign Institutions + | 1.25% | 1.69% | 1.23% | 1.62% | 2.88% |
Domestic Institutions + | 18.91% | 19.56% | 18.07% | 17.77% | 17.11% |
Government | 0% | 0% | 0% | 0% | 0% |
Public | 21.01% | 20.01% | 22.01% | 21.92% | 21.32% |
Others | 0.03% | 0% | 0% | 0% | 0% |
About Indoco Remedies
Indoco Remedies is a Public Limited Listed company incorporated on 23/08/1947 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L85190MH1947PLC005913 and registration number is 005913. Currently Company is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company’s Total Operating Revenue is Rs. 1790.81 Cr. and Equity Capital is Rs. 18.44 Cr. for the Year ended 31/03/2024. Read More
Parent Organisation
Not Applicable
Founded
1947
Managing Director
Ms. Aditi Panandikar
NSE Symbol
INDOCO
Indoco Remedies Management
Name | Designation |
---|---|
Mr. Suresh G Kare | Chairman |
Ms. Aditi Panandikar | Managing Director |
Mr. Sundeep V Bambolkar | Joint Managing Director |
Dr. Anand Nadkarni | Non Executive Director |
Mr. Satish Shenoy | Independent Director |
Mr. Ajay Mulgaokar | Independent Director |
Dr.(Ms.) Vasudha V Kamat | Independent Director |
Mr. Abhijit Y Gore | Independent Director |
Peer Comparison
Stocks | Market Cap | Market Price | 52 Week Low-High |
---|---|---|---|
Sun Pharmaceutical Industries | ₹4,10,130.32 | ₹1,709.35 ₹1,770.00(-3.43%) | ₹1,376.750 - ₹1,960.200 |
Divi's Laboratories | ₹1,45,552.44 | ₹5,482.85 ₹5,763.00(-4.86%) | ₹3,613.550 - ₹6,448.750 |
Cipla | ₹1,14,298.01 | ₹1,415.25 ₹1,495.70(-5.38%) | ₹1,317.600 - ₹1,702.000 |
Torrent Pharmaceuticals | ₹1,11,230.09 | ₹3,286.50 ₹3,247.70(1.19%) | ₹2,508.650 - ₹3,589.950 |
Mankind Pharma | ₹1,01,131.25 | ₹2,451.20 ₹2,427.70(0.97%) | ₹1,910.100 - ₹3,050.000 |
FAQs on Indoco Remedies
What is the share price of Indoco Remedies?
The share price of Indoco Remedies on 04 Apr, 2025 is ₹ 249.18.
What is 52W high and 52W low share price of Indoco Remedies?
The highest and lowest 52W share prices of Indoco Remedies are ₹ 385.500 and ₹ 190.000
What is the market cap of Indoco Remedies?
The market capitalization of Indoco Remedies as of 04 Apr, 2025 is ₹ 2,298.63 Crores
What is the P/E ratio of Indoco Remedies?
The current P/E ratio of Indoco Remedies as of 04 Apr, 2025 is 44.73
What is the PB ratio of Indoco Remedies?
The PB ratio of Indoco Remedies as of 04 Apr, 2025 is 2.07
Top Gainers
₹18.07
₹15.14 (0.19%)
₹66.60
₹57.80 (0.15%)
₹88.74
₹73.95 (0.20%)
₹197.50
₹167.35 (0.18%)
Top Losers
₹307.35
₹368.55 (-0.17%)
₹108.20
₹127.00 (-0.15%)
₹0.54
₹1.03 (-0.48%)
₹2,705.55
₹3,206.90 (-0.16%)
Market Indices
Sensex
₹75,364.69
₹76,295.36 (-0.01%)